SQUAMOUS CELL CARCINOMA
Study #S1400FA Phase II Study of MEDI4736 (Durvalumab) Plus Tremelimumab as Therapy for Patients with Previously Treated Anti-PD-1/PD-L1 Resistant Stage IV Squamous Cell Lung Cancer
Back To Clinical Trials
Covid-19 Alert: if you have cold or flu-like symptoms (fever, cough, difficulty breathing, body aches, or chills, headache, sore throat, or loss of taste or smell), you must call us at 515.282.2921 before coming into Mission Cancer + Blood, even if you have an appointment. Tell us about your symptoms before coming in – Thank you!